tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer in Severe Asthma Treatment
PremiumCompany AnnouncementsAstraZeneca’s Tezepelumab Study: A Potential Game-Changer in Severe Asthma Treatment
2d ago
AstraZeneca Completes Key Study on AZD2389’s Drug Interaction Effects
Premium
Company Announcements
AstraZeneca Completes Key Study on AZD2389’s Drug Interaction Effects
2d ago
AstraZeneca’s Phase III Study on Anifrolumab for Cutaneous Lupus: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Phase III Study on Anifrolumab for Cutaneous Lupus: Key Insights for Investors
2d ago
AstraZeneca’s Phase I Study on AZD6234: A Potential Game-Changer in Obesity Treatment
PremiumCompany AnnouncementsAstraZeneca’s Phase I Study on AZD6234: A Potential Game-Changer in Obesity Treatment
8d ago
AstraZeneca’s Phase III Study on Benralizumab: A Potential Game-Changer for Pediatric Asthma
Premium
Company Announcements
AstraZeneca’s Phase III Study on Benralizumab: A Potential Game-Changer for Pediatric Asthma
9d ago
AstraZeneca’s New Obesity Drug: A Potential Game-Changer?
Premium
Company Announcements
AstraZeneca’s New Obesity Drug: A Potential Game-Changer?
10d ago
AstraZeneca’s Latest Study on AZD2389: What Investors Need to Know
PremiumCompany AnnouncementsAstraZeneca’s Latest Study on AZD2389: What Investors Need to Know
15d ago
AstraZeneca’s New Ovarian Cancer Study: What Investors Need to Know
Premium
Company Announcements
AstraZeneca’s New Ovarian Cancer Study: What Investors Need to Know
15d ago
AstraZeneca’s Tozorakimab Study: A New Frontier in Drug Delivery
Premium
Company Announcements
AstraZeneca’s Tozorakimab Study: A New Frontier in Drug Delivery
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100